Shanghai HeartCare Medical Technology Corporation Limited (6609.HK)

16,320 +0,120 (+0,74%) A partir del 03:50PM HKT. Mercado abierto.

Shanghai HeartCare Medical Technology Corporation Limited

Building 38
Floor 1 and 3 No. 356, Zhengbo Road Lingang New District, Pilot Free Trade Zone
Shanghai
China
86 21 3752 6556
https://www.heartcare.com.cn

Sector(es): Healthcare
Sector: Medical Devices
Empleados a tiempo completo: 368

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Guohui Wang	Chairman & CEO	1,26M	N/A	1979
Ms. Kun Zhang	Deputy GM & Executive Director	1,15M	N/A	1979
Mr. Jiawei Wei	Deputy GM & Executive Director	1,13M	N/A	1979
Mr. Han Zhang	CFO & Joint Company Secretary	N/A	N/A	1988
Mr. Zongyu Xue	VP of Quality Regulation & Employee Representative Supervisor	N/A	N/A	1985
Ms. Siu Ying Kwok	Joint Company Secretary	N/A	N/A	1985

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en HKD.

Descripción

Shanghai HeartCare Medical Technology Corporation Limited researches, develops, manufacture, and sells neuro-interventional medical devices in Mainland China. The company offers ischemic stroke thrombectomy devices, such as Captor thrombectomy device, and aspiration catheter and pump; intracranial stenosis treatment devices comprising intracranial drug-eluting balloon catheter and embolization protection system; hemorrhagic stroke treatment devices, including coil embolization assistant stent and flow diverter device; and ischemic stroke prevention devices, such as LAA occlude. It also provides vascular access devices comprising distal access catheter, microcatheter, balloon guiding catheter, vascular closure device, support catheter, neuro-interventional microcatheter, micro guidewire, microcatheter for coiling, microcatheter for flow diverter device, and navigation catheter. The company's products are used for acute ischemic stroke and neurovascular stenosis treatment, hemorrhagic stroke treatment, ischemic stroke prevention, and interventional access. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.

Gobierno corporativo

El ISS Governance QualityScore de Shanghai HeartCare Medical Technology Corporation Limited, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.